Concepedia

Publication | Open Access

Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

DOIFull Paper Access

125

Citations

17

References

2017

Year

Larisa Broglie, Lauren Pommert, Sridhar Rao, Monica S. Thakar, Rachel Phelan, David M. Margolis, Julie‐An Talano
Blood Advances

Abstract

Optimal salvage therapy for refractory HLH is unknown.In our patient, ruxolitinib treatment led to clinical remission of refractory HLH.

References

YearCitations

Page 1